Intranasal epinephrine spray ARS-2 may offer a safe and effective needle-free treatment alternative for chronic spontaneous urticaria, results from a phase 2 study suggested. Epinephrine has been used ...

Novartis has claimed a first-in-class regulatory approval in the US for oral BTK inhibitor remibrutinib as a second-line treatment for chronic spontaneous urticaria (CSU), also known as chronic hives.

Novartis is just months away from filing for approval of oral BTK inhibitor remibrutinib as a treatment for chronic spontaneous urticaria – also known as chronic hives – after reporting long-term data ...

Zia Sherrell is a health journalist, copywriter, and freelance writing mentor with over 1 million published words across major publications, including Healthline, Medical News Today, Business Insider, ...

Discover common skin care ingredients that can cause allergic reactions and learn how to identify them in your products. Chronic idiopathic urticaria, also known as chronic hives or chronic ...

Daniel More, MD, FAAAAI, FACAAI, FACP, is a board-certified allergist and former clinical immunologist at Allergy Partners of the Central California Coast. Hives are round, oval, or irregularly shaped ...

CSU is a skin condition that causes hives and swelling lasting six weeks or more. The cause of the condition is often unknown, but in the majority of cases it's linked to an overactive immune system.